IMPACT FACTOR JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOGS LaTeX 5G Tutorial
 




Molecular Pharmaceutics - Impact Factor, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and other Important Metrics


Impact Factor

4.57

H-Index

110

Rank

2541

SJR

1.402

Note: The impact factor shown here is equivalent to citescore and is, therefore, used as a replacement for the same. Citescore is produced by Scopus, and can be a little higher or different compared to the impact factor produced by Journal Citation Report. Please refer to Web of Science data source for checking the exact journal impact factor ™ (Thomson Reuters) metric.

Title Molecular Pharmaceutics
Publication Type journal
Subject Area, Categories, Scope Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2)
h-index 110
Overall Rank/Ranking 2541
SCImago Journal Rank (SJR) 1.402
Impact Factor 4.57
Publisher American Chemical Society
Country United States
ISSN 15438384, 15438392



About Molecular Pharmaceutics


Molecular Pharmaceutics is a journal covering the technologies/fields/categories related to Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2). It is published by American Chemical Society. The overall rank of Molecular Pharmaceutics is 2541. According to SCImago Journal Rank (SJR), this journal is ranked 1.402. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 110. The best quartile for this journal is Q1.

The ISSN of Molecular Pharmaceutics journal is 15438384, 15438392. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Molecular Pharmaceutics is cited by a total of 6040 articles during the last 3 years (Preceding 2018).

Molecular Pharmaceutics Impact Factor 2018-2019


The impact factor (IF) 2018 of Molecular Pharmaceutics is 4.57, which is computed in 2019 as per it's definition. Molecular Pharmaceutics IF is decreased by a factor of 0.25 and approximate percentage change is -5.19% when compared to preceding year 2017, which shows a falling trend. The impact factor (IF), also denoted as Journal impact factor (JIF), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal.



Table Setting

Molecular Pharmaceutics Impact Factor 2019 Prediction


IF 2018 of Molecular Pharmaceutics is 4.57. If the same downward trend persists, impact factor of joule may fall in 2019 as well.

Molecular Pharmaceutics h-index


  Table Setting

Molecular Pharmaceutics has an h-index of 110. It means 110 articles of this journal have more than 110 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.

Molecular Pharmaceutics ISSN


The ISSN of Molecular Pharmaceutics is 15438384, 15438392. ISSN stands for International Standard Serial Number. An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Molecular Pharmaceutics Rank and SCImago Journal Rank (SJR)


The overall rank of Molecular Pharmaceutics is 2541. According to SCImago Journal Rank (SJR), this journal is ranked 1.402. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

Molecular Pharmaceutics Publisher


Table Setting

Molecular Pharmaceutics is published by American Chemical Society. It's publishing house is located in United States. Coverage history of this journal is as following: 2004-ongoing. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.

How to publish in Molecular Pharmaceutics


If your research field is/are related to Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2), then you can visit the official website of the journal.

Acceptance Rate


To check the acceptance rate of this journal, visit here.

Call for Paper, Submission Guidelines, Notification Date, and Submission Deadline 2020/2019


Visit the official website of the journal/conference for the call for paper, submission guidelines, notification date, and submission deadlines.


Source: https://www.scimagojr.com/journalrank.php



Impact Factor, h-Index, and other important details of other Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Factor
International Journal of Obesity journal 968 Nature Publishing Group 204 4.36
Information Polity journal 15250 IOS Press 31 1.71
2016 Progress in Applied Electrical Engineering, PAEE 2016 conference and proceedings 29789 2 0.29
Russian Journal of Developmental Biology journal 18561 Maik Nauka Publishing / Springer SBM 11 0.34
Proceedings - International Conference on Pattern Recognition conference and proceedings 14990 95 1.22
Chemical Data Collections journal 19343 Elsevier BV 5 0.94
Revista Catalana d'Ornitologia journal 27288 Institut Catala d'Ornitologia 4 0.27
Law and Humanities journal 23651 Taylor and Francis Ltd. 3 0.24
Expert Review of Proteomics journal 4715 Taylor & Francis 53 2.87
Journal of Applied Biological Sciences journal 27819 Nobel Publishing 8 0.06

Check complete list

Year wise Impact Factor (IF) of Molecular Pharmaceutics

Year Impact Factor (IF)
2019Coming Soon
20184.57
20174.82
20164.99
20155.1
20145.1



Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Molecular Therapy
Cell Press | United States

Cell Chemical Biology
Elsevier Inc. | United States

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Current Opinion in Pharmacology
Elsevier BV | Netherlands

Journal of Medicinal Chemistry
American Chemical Society | United States

Protein & Cell
Springer Verlag | Germany

Drug Discovery Today
Elsevier BV | Netherlands

Vaccines
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland


Top Journals/Conferences in Pharmaceutical Science

Nano Today
Elsevier BV | Netherlands

Advanced Drug Delivery Reviews
Elsevier BV | Netherlands

International Journal of Pharmaceutical Investigation
Wolters Kluwer Medknow Publications | India

Journal of Controlled Release
Elsevier BV | Netherlands

Advanced healthcare materials
John Wiley and Sons Ltd | United Kingdom

Nanotechnology, Science and Applications
Dove Medical Press Ltd. | New Zealand

Bioconjugate Chemistry
American Chemical Society | United States

Nanomedicine: Nanotechnology, Biology, and Medicine
Elsevier BV | Netherlands

Expert Opinion on Drug Delivery
Taylor & Francis | United Kingdom

European Journal of Pharmaceutics and Biopharmaceutics
Elsevier BV | Netherlands


Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central | United Kingdom

EMBO Molecular Medicine
John Wiley & Sons Ltd. | United Kingdom

Trends in Molecular Medicine
Elsevier BV | Netherlands

Journal for ImmunoTherapy of Cancer
BioMed Central | United Kingdom

Molecular Therapy
Cell Press | United States

Molecular Cancer
BioMed Central | United Kingdom

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom